Millennium Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Millennium Management's DNA Position: Q3 2026 in Review
Millennium Management reduced its Ginkgo Bioworks (DNA) stake by 12% in Q3 2026, selling an estimated $645K and leaving 559,478 shares worth $7.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2659.
Millennium Management first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $17.5M in Q3 2021. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Millennium Management held 559,478 shares of Ginkgo Bioworks worth $7.18M as of Q3 2026.
- Millennium Management sold 79,198 Ginkgo Bioworks shares in Q3 2026, an estimated $645K.
- Ginkgo Bioworks made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #2659 holding.
- Millennium Management first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
- Millennium Management's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.